RMC «HOME OF PHARMACY» is registered in the Chestny Znak system. Acceptance of drugs registered in the Russian Federation can be carried out by direct or reverse acceptance, at the discretion of the Sponsor. Withdrawal from circulation of labeled medicinal products for research is carried out using 552 schemes (withdrawal from circulation) with code 9 (for the purposes of clinical trials) or with code 13 (write-off without transfer for destruction).
News
On June 30 – July 01, 2022, staff of «RMC «HOME OF PHARMACY» took part in the III GLP-PLANET conference, in which representatives of the regulator, leading specialists of testing facilities and pharmaceutical companies discussed the most important issues arising during preclinical studies. The results of the conference can be found on the website.
On November 23, the monograph “GLP-PLANET Consultant. The opinion of the pharmaceutical industry”. The monograph provides the opinions of leading experts in the pharmaceutical industry – experts in the field of preclinical research, representatives of pharmaceutical companies and regulatory authorities.
The full text is available only in Russian
On July 5-6, 2021, staff of «RMC «HOME OF PHARMACY» took part in the II GLP-PLANET conference, in which international experts, representatives of the regulator, leading specialists of testing facilities and pharmaceutical companies discussed the most important issues arising during preclinical studies. The results of the conference can be found on the website.
Training sessions are conducted only in Russian
The specialists of our preclinical center continue their corporate work on the development, adaptation and implementation of the process of reproduction of rarely used laboratory animals. At the end of January the first offspring of the Russian Blue Cats was obtained in the cattery of RMC «HOME OF PHARMACY».
Every year on February 8, the Russian scientific community celebrates its professional holiday – the Day of Russian Science.
Dear colleagues, we wish you new breakthrough discoveries, success in scientific research, inexhaustible activity and optimism, good health, good mood and happiness.
5-6 июля 2021 года в научной столице России – Санкт-Петербурге пройдет II конференция GLP-PLANET , в рамках которой международные эксперты, представители регулятора, ведущие специалисты испытательных центров и фармацевтических компаний обсудят важнейшие вопросы, возникающие при проведении доклинических исследований:
- Эволюция требований к качеству доклинических исследований.
- Доклинические исследования: о чем не принято писать в научном отчете?
- Благополучие лабораторных животных.
- Разнообразие тест-систем и трансляционность полученных данных в клиническую практику.
- Аналитические лаборатории в доклинических и клинических исследованиях
- GLP-инжиниринг.
- Профессиональная подготовка специалистов в области доклинических исследований.